中文
中文

News

USTAR MultNAT MTB/RIF Assay officially approved by the China National Medical Products Administration (NMPA)!

A "Global Solution" for innovating the diagnosis of drug-resistant tuberculosis.
09.06.2025

Ustar Biotech and University Indonesia officially signed a Memorandum of Understanding (MoU) in Jakarta

University Indonesia, was founded in 1849. It is the oldest higher education institution in Indonesia and a world-leading research university
21.08.2025

Ustar Biotechnology’s Monkeypox Virus Assays Receive WHO Emergency Use Listing (EUL).

The first cerctificate in China, which passed WHO Emergency Use Listing (EUL) approval for the Ustars’ Molecular POC Monkeypox Virus (MPXV ) Assay
28.05.2025
Reagent

MultNAT

PortNAT

EasyNAT

Consumables

System

MultNAT

PortNAT

EasyNAT

Solution
About us

Company Profile

R&D Strength

Social Responsibility